1. Home
  2. AGS vs FDMT Comparison

AGS vs FDMT Comparison

Compare AGS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGS
  • FDMT
  • Stock Information
  • Founded
  • AGS 2005
  • FDMT 2013
  • Country
  • AGS United States
  • FDMT United States
  • Employees
  • AGS N/A
  • FDMT N/A
  • Industry
  • AGS Miscellaneous manufacturing industries
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGS Consumer Discretionary
  • FDMT Health Care
  • Exchange
  • AGS Nasdaq
  • FDMT Nasdaq
  • Market Cap
  • AGS 473.9M
  • FDMT 420.7M
  • IPO Year
  • AGS 2018
  • FDMT 2020
  • Fundamental
  • Price
  • AGS $11.55
  • FDMT $6.04
  • Analyst Decision
  • AGS Hold
  • FDMT Buy
  • Analyst Count
  • AGS 4
  • FDMT 10
  • Target Price
  • AGS $12.63
  • FDMT $42.44
  • AVG Volume (30 Days)
  • AGS 213.1K
  • FDMT 724.9K
  • Earning Date
  • AGS 11-07-2024
  • FDMT 11-13-2024
  • Dividend Yield
  • AGS N/A
  • FDMT N/A
  • EPS Growth
  • AGS 150.52
  • FDMT N/A
  • EPS
  • AGS 0.17
  • FDMT N/A
  • Revenue
  • AGS $386,033,000.00
  • FDMT $17,000.00
  • Revenue This Year
  • AGS $10.87
  • FDMT N/A
  • Revenue Next Year
  • AGS $4.33
  • FDMT $87.55
  • P/E Ratio
  • AGS $67.51
  • FDMT N/A
  • Revenue Growth
  • AGS 12.18
  • FDMT N/A
  • 52 Week Low
  • AGS $7.54
  • FDMT $6.32
  • 52 Week High
  • AGS $11.75
  • FDMT $36.25
  • Technical
  • Relative Strength Index (RSI)
  • AGS 56.78
  • FDMT 28.94
  • Support Level
  • AGS $11.36
  • FDMT $6.42
  • Resistance Level
  • AGS $11.50
  • FDMT $7.58
  • Average True Range (ATR)
  • AGS 0.07
  • FDMT 0.42
  • MACD
  • AGS 0.00
  • FDMT -0.06
  • Stochastic Oscillator
  • AGS 77.42
  • FDMT 1.85

About AGS PlayAGS Inc.

PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: